News for GENEREX BIOTECHNOLOGY CORP (GNBT)

News for GENEREX BIOTECHNOLOGY CORP
Date Headline
Dec 07, 2017 11:30 AM Generex Announces Collaboration with Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in China
Nov 30, 2017 09:00 AM Generex Announces Upgrade to OTCQB® Venture Market
Nov 27, 2017 09:00 AM Generex Announces Results of Annual Stockholders’ Meeting
Oct 12, 2017 09:00 AM Generex Announces Exclusive Distribution Contract For Rapid 1-2-3® Hema HIV EXPRESS® in Chile
Sep 20, 2017 09:30 AM Generex Announces New Clinical Trial of Hema Diagnostic Systems’ Rapid 1-2-3® Tuberculosis Point-of-Care Tests
Sep 12, 2017 09:30 AM Generex Announces Order for Hema Diagnostic Systems’ Rapid 1-2-3® Hema HIV EXPRESS® in Chile
Aug 07, 2017 09:30 AM Generex Provides Summary of Ii-Key Hybrid Vaccine Platform
Jul 31, 2017 09:30 AM Generex Announces Collaboration with Merck to Evaluate KEYTRUDA® (pembrolizumab) in Combination with AE37 in Patients with Triple-Negative Breast Cancer
Mar 14, 2017 09:00 AM Generex Announces Reverse Stock Split
Feb 21, 2017 09:30 AM Generex Provides Access Information for Investor Conference Call Scheduled for February 22, 2017